(Q44208502)

English

Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model (English)

1 reference

Europe PubMed Central

30 November 2017

meningoencephalitis

0 references

1 reference

based on heuristic

inferred from title

5-fluorocytosine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hossain MA

1

1 reference

Europe PubMed Central

30 November 2017

Mukherjee PK

2

1 reference

Europe PubMed Central

30 November 2017

Reyes G

3

1 reference

Europe PubMed Central

30 November 2017

Long L

4

1 reference

Europe PubMed Central

30 November 2017

Ghannoum MA

5

1 reference

Europe PubMed Central

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

30 November 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

30 November 2017

14

1 reference

Europe PubMed Central

30 November 2017

4

1 reference

Europe PubMed Central

30 November 2017

351-360

1 reference

Europe PubMed Central

30 November 2017

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Cryptococcosis: clinical and biological aspects

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Mycoses in AIDS.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Immune reconstitution in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Opportunistic infections in HIV disease: down but not out.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

High-dose therapy with fluconazole > or = 800 mg day-1.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

The exciting future of antifungal therapy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.4.351

21 January 2018

Identifiers

10.1179/JOC.2002.14.4.351

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44208502&oldid=2108550640"